Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Advent Technologies Holdings, Inc. (ADN)

$0.91
-0.01 (-0.65%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Company Profile

Price Chart

Loading chart...

At a glance

Strategic Transformation: Advent Technologies (ADN) is undergoing a radical business model shift, moving away from capital-intensive, low-margin fuel cell system sales to focus exclusively on high-temperature Membrane Electrode Assembly (MEA) innovation, intellectual property, and manufacturing scale, aiming for a high-margin, low-CapEx licensing model by 2026.

Differentiated Technology: The core of Advent's thesis lies in its proprietary Ion Pair MEA technology, which promises a 2x increase in power density and 2x longer lifetime compared to previous state-of-the-art HT-PEM fuel cells, enabling significantly lower costs and superior performance in demanding applications like aviation, heavy-duty transport, and data centers.

Critical Partnerships & Grants: The company's future hinges on strategic joint development agreements with global OEMs (Airbus (EADSY) , Hyundai Motor Company (HYMTF) , US DoD, and four other top automakers) and substantial non-dilutive grant funding, notably the $34.53 million RHyno Project from the EU Innovation Fund and the long-delayed €782.1 million Green HiPo project.